The relevant information included in this section is exactly as published on the website of the National Securities Market Commission (CNMV)

Filter results
Date Title PDF
28/07/2021 First half 2021 results press release
13/05/2021 First quarter 2021 results press release
29/04/2021 ROVI increases its fill-finish capacity for the COVID-19 Vaccine Moderna
12/04/2021 ROVI participates in the manufacture of the active substance of Moderna’s COVID-19 vaccine
2/03/2021 Update on Doria® regulatory processes
24/02/2021 Full year 2020 results press release